Estefany Rios-Guzman

1.7k total citations
8 papers, 82 citations indexed

About

Estefany Rios-Guzman is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Estefany Rios-Guzman has authored 8 papers receiving a total of 82 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Estefany Rios-Guzman's work include SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (3 papers). Estefany Rios-Guzman is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), COVID-19 Clinical Research Studies (3 papers) and SARS-CoV-2 detection and testing (3 papers). Estefany Rios-Guzman collaborates with scholars based in United States. Estefany Rios-Guzman's co-authors include Judd F. Hultquist, Ramón Lorenzo-Redondo, Egon A. Ozer, Hannah Nam, Michael G. Ison, Arghavan Alisoltani, Lacy M. Simons, Anna Pawlowski, Daniel Schimmel and Chao Qi and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Viruses.

In The Last Decade

Estefany Rios-Guzman

6 papers receiving 82 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Estefany Rios-Guzman United States	4	48	39	22	11	8	8	82
C. M. Haring Germany	3	30 0.6×	95 2.4×	16 0.7×	25 2.3×	9 1.1×	7	147
Natasha Loevy Switzerland	3	33 0.7×	113 2.9×	13 0.6×	11 1.0×	15 1.9×	6	137
Sapeckshita Agrawal United States	2	68 1.4×	41 1.1×	37 1.7×	8 0.7×	9 1.1×	2	98
Heng Gee Lee Malaysia	4	66 1.4×	83 2.1×	29 1.3×	6 0.5×	23 2.9×	9	120
Aurélien Marc France	4	32 0.7×	61 1.6×	20 0.9×	13 1.2×	6 0.8×	4	106
Junko Terada-Hirashima Japan	5	26 0.5×	77 2.0×	8 0.4×	24 2.2×	3 0.4×	24	119
Filippos Filippatos Greece	6	19 0.4×	112 2.9×	9 0.4×	23 2.1×	20 2.5×	22	138
Cristina Costales United States	5	21 0.4×	73 1.9×	5 0.2×	10 0.9×	19 2.4×	18	110
M. V. M. Divarathna Sri Lanka	6	70 1.5×	40 1.0×	14 0.6×	11 1.0×	10 1.3×	8	81

Countries citing papers authored by Estefany Rios-Guzman

Since Specialization

Citations

This map shows the geographic impact of Estefany Rios-Guzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estefany Rios-Guzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estefany Rios-Guzman more than expected).

Fields of papers citing papers by Estefany Rios-Guzman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estefany Rios-Guzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estefany Rios-Guzman. The network helps show where Estefany Rios-Guzman may publish in the future.

Co-authorship network of co-authors of Estefany Rios-Guzman

This figure shows the co-authorship network connecting the top 25 collaborators of Estefany Rios-Guzman. A scholar is included among the top collaborators of Estefany Rios-Guzman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estefany Rios-Guzman. Estefany Rios-Guzman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Simons, Lacy M., Estefany Rios-Guzman, Arghavan Alisoltani, et al.. (2025). The impact of remdesivir on SARS-CoV-2 evolution in vivo. JCI Insight. 10(4). 3 indexed citations

Rios-Guzman, Estefany, Lacy M. Simons, David B. Williams, et al.. (2025). Intra-Host Evolution of SARS-CoV-2 During Persistent Infection of Pediatric COVID-19 Patients. Viruses. 17(10). 1313–1313.

Rios-Guzman, Estefany, Lacy M. Simons, Anna Pawlowski, et al.. (2024). Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic. Nature Communications. 15(1). 3374–3374. 30 indexed citations

Simons, Lacy M., Estefany Rios-Guzman, Arghavan Alisoltani, et al.. (2024). Integration of individualized and population-level molecular epidemiology data to model COVID-19 outcomes. Cell Reports Medicine. 5(1). 101361–101361.

Rios-Guzman, Estefany, Lacy M. Simons, Rachel Palmieri Weber, et al.. (2024). COVID-19 outbreak and genomic investigation in an inpatient behavioral health unit. SHILAP Revista de lepidopterología. 4(1). e62–e62. 1 indexed citations

Rios-Guzman, Estefany, et al.. (2022). Challenges and Opportunities for Global Genomic Surveillance Strategies in the COVID-19 Era. Viruses. 14(11). 2532–2532. 27 indexed citations

Rios-Guzman, Estefany & Judd F. Hultquist. (2022). Clinical and biological consequences of respiratory syncytial virus genetic diversity. Therapeutic Advances in Infectious Disease. 9. 2008362907–2008362907. 20 indexed citations

Mylvaganam, Ruben, et al.. (2021). Pulmonary Vascular Hemodynamics and the Percentage of Non-Classical Monocytes in Chronic Thromboembolic Pulmonary Hypertension. A3638–A3638. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact